Hybio Pharmaceutical Co., Ltd. (SHE:300199)

China · Delayed Price · Currency is CNY

18.96

+0.43 (2.32%)

Mar 19, 2026, 3:08 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicine Manufacturing	590.20M	431.38M	704.32M	735.97M	721.72M
Medicine Manufacturing Growth	36.82%	-38.75%	-4.30%	1.97%	17.51%
Total	590.20M	431.38M	704.32M	735.97M	721.72M
Total Growth	36.82%	-38.75%	-4.30%	1.97%	17.51%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	265.02M	319.17M	625.06M	689.03M	679.69M
China Growth	-16.97%	-48.94%	-9.28%	1.37%	-
Foreign	325.18M	112.21M	79.26M	46.94M	42.04M
Foreign Growth	189.79%	41.58%	68.86%	11.66%	-
Total	590.20M	431.38M	704.32M	735.97M	721.72M
Total Growth	36.82%	-38.75%	-4.30%	1.97%	-

Source: S&P Global Market Intelligence.